4 unchanged sentences
Not applicable.
+Added: Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
+Added: Market information for common stock
+Added: Our common stock is traded on the Nasdaq Global Select Market, or Nasdaq, under the symbol “GH.”
+Added: Holders of record
+Added: As of February 14, 2025, there were 47 holders of record of our common stock.
+Added: Because many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.
+Added: Dividend policy
+Added: We have never declared or paid any dividends on our common stock.
+Added: We currently intend to retain all available funds and any future earnings for the operation and expansion of our business.
+Added: Accordingly, we do not anticipate declaring or paying dividends in the foreseeable future.
+Added: The payment of any future dividends will be at the discretion of our board of directors and will depend on our results of operations, capital requirements, financial condition, prospects, contractual arrangements, including any limitations on payment of dividends, and other factors that the board may deem relevant.
+Added: Unregistered sales of equity securities
+Added: Purchases of equity securities by the issuer and affiliated purchasers
+Added: Securities authorized for issuance under equity compensation plans
+Added: The information required by this item with respect to our equity compensation plans is incorporated by reference to our definitive proxy statement relating to our 2025 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year to which this Annual Report on Form 10-K relates, or the 2025 Proxy Statement.
+Added: Stock performance graph
+Added: The graph below shows a comparison of five-year cumulative total return to stockholders of our common stock relative to the Nasdaq Composite Index and the Nasdaq Biotechnology Index through December 31, 2024.
+Added: The graph assumes that $100 was invested in each of our common stock, the Nasdaq Composite and the Nasdaq Biotechnology at their respective closing prices on December 31, 2019 and assumes reinvestment of gross dividends.
+Added: The stock price performance shown in the graph represents past performance and should not be considered an indication of future stock price performance.
+Added: This graph is not “soliciting material,” is not deemed “filed” with the SEC and is not to be incorporated by reference into any of our filings under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.